Literature DB >> 25696566

Neointimal hyperplasia and endothelial function after percutaneous coronary intervention.

O Sorop, H M M van Beusekom, W J van der Giessen.   

Abstract

Percutaneous coronary revascularisation has become much safer and efficacious since its introduction more than 25 years ago. Currently, the need for surgical backup is small and the rate of late complications is lower than 10%. Further improvements are being studied, especially directed towards more biocompatible stents, using pharmacological principles with wider therapeutic windows and enhancing the vascular healing response/reendothelialisation. This article reviews several activities within the ICIN theme group `Vessel Wall'.

Entities:  

Year:  2006        PMID： 25696566      PMCID： PMC2557312     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  11 in total

1.  Long-term endothelial dysfunction after coronary artery stenting.

Authors:  P R Caramori; V C Lima; P H Seidelin; G E Newton; J D Parker; A G Adelman
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

2.  In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts.

Authors:  Joris I Rotmans; Jan M M Heyligers; Hence J M Verhagen; Evelyn Velema; Machiel M Nagtegaal; Dominique P V de Kleijn; Flip G de Groot; Erik S G Stroes; Gerard Pasterkamp
Journal:  Circulation       Date:  2005-06-27       Impact factor: 29.690

3.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

Authors:  Eugène P McFadden; Eugenio Stabile; Evelyn Regar; Edouard Cheneau; Andrew T L Ong; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; August D Pichard; Lowell F Satler; Ron Waksman; Patrick W Serruys
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

4.  Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries.

Authors:  H M van Beusekom; D M Whelan; S H Hofma; S C Krabbendam; V W van Hinsbergh; P D Verdouw; W J van der Giessen
Journal:  J Am Coll Cardiol       Date:  1998-10       Impact factor: 24.094

5.  Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients.

Authors:  Jiro Aoki; Alexandre C Abizaid; Patrick W Serruys; Andrew T L Ong; Eric Boersma; J Eduardo Sousa; Nico Bruining
Journal:  J Am Coll Cardiol       Date:  2005-10-10       Impact factor: 24.094

6.  Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design.

Authors:  Jan Steffel; Roberto A Latini; Alexander Akhmedov; Dorothee Zimmermann; Pamela Zimmerling; Thomas F Lüscher; Felix C Tanner
Journal:  Circulation       Date:  2005-09-19       Impact factor: 29.690

7.  Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.

Authors:  J Eduardo Sousa; Marco A Costa; Alexandre Abizaid; Fausto Feres; Ana C Seixas; Luiz F Tanajura; Luiz A Mattos; Robert Falotico; Judith Jaeger; Jeffrey J Popma; Patrick W Serruys; Amanda G M R Sousa
Journal:  Circulation       Date:  2005-04-25       Impact factor: 29.690

8.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.

Authors:  W J van der Giessen; A M Lincoff; R S Schwartz; H M van Beusekom; P W Serruys; D R Holmes; S G Ellis; E J Topol
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

9.  Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro.

Authors:  M Y Flugelman; R Virmani; M B Leon; R L Bowman; D A Dichek
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

10.  Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Authors:  Renu Virmani; Giulio Guagliumi; Andrew Farb; Giuseppe Musumeci; Niccolo Grieco; Teresio Motta; Laurian Mihalcsik; Maurizio Tespili; Orazio Valsecchi; Frank D Kolodgie
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.